Literature DB >> 458797

Classification of drugs by discriminant analysis using fragment molecular connectivity values.

D R Henry, J H Block.   

Abstract

An investigation was made into the use of linear and quadratic discriminant analysis, along with K nearest-neighbor analysis, in the classification of a set of 51 compounds which were divided into five therapeutic categories. By superimposing each compound on a pattern structure, as first proposed by Cammarata, eight positions were assigned on the molecule. Each position was coded with the numerical value of a descriptor index. Relative molar refraction, which was the index used by Cammarata, was compared with a number of molecular connective indices. For each of the indices studied, it was found that only four of the eight positions contributed significantly to between-class differences. It was also found that first-order molecular connectivity, calculated as the sum of the contributions of each of the bonds joining a given position, resulted in consistently fewer misclassifications as compared with the other indices. Using first-order molecular connectivity, validation procedures were performed on the original set of compounds, on random samples drawn from this set, and on a set of ten compounds not included in the analysis. The results obtained were highly data dependent, but they, nevertheless, suggest that molecular connectivity indices should prove useful in structural classification procedures.

Mesh:

Substances:

Year:  1979        PMID: 458797     DOI: 10.1021/jm00191a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

Review 1.  Substructural QSAR approaches and topological pharmacophores.

Authors:  R Franke; S Huebel; W J Streich
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

Review 2.  Machine Learning Based Toxicity Prediction: From Chemical Structural Description to Transcriptome Analysis.

Authors:  Yunyi Wu; Guanyu Wang
Journal:  Int J Mol Sci       Date:  2018-08-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.